Ann: Exopharm Gains US Patent for LEAP Technology, page-6

The lack of patience or understanding about how deals work in the bio space is breathtaking. The company has been completely thwarted by the covid restrictions given their proprietary set up here in Melbourne . No one could come here . These things always take longer than anyone thinks anyway.

If Dixon says Ex1 is in discussions with potential partners that's what's happening.

2 or 3 years isn't very long in this sector. Have a look at the charts of any bio that's had success in the country or even elsewhere. It's a rough ride.

I couldn't care less what the market does. This will be a successful company. In whatever time it takes to become one . Everybody including myself got a little ahead of ourselves but it doesn't lessen my confidence in what they are achieving and what the ultimate outcome will be.

But for those who don't see it that way just move on. There's plenty of other bios out there doing a lot worse than this one if you want to put your money there.